How does verapamil affect heart rate?

Baak MA van, Jennen W, Muijtjens A, Verstappen FTJ (1985a) Effects of acute an chronic metoprolol administration during submaximal and maximal exercise. Int J Sports Med 6:347–352

PubMed  Google Scholar 

Baak MA van, Jennen W, Verstappen FTJ (1985b) Maximal aerobic power and blood pressure in normotensive subjects after acute and chronic administration of metoprolol. Eur J Clin Pharmacol 28:143–148

Article  PubMed  Google Scholar 

Böhm ROB, Arends BG, Hooff MEJ van, Rahn KH, Baak MA van (1985) Submaximal exercise tolerance during longterm antihypertensive therapy with three different betablockers. Hochdruck 6:68

Google Scholar 

Borg GAV (1973) Perceived exertion: a note on “history” and methods. Med Sci Sports 5:90–93

PubMed  CAS  Google Scholar 

Buehler FR, HÚlthen UL, Kiowski W, Mueller FB, Bolli P (1982) The place of the calcium antagonist verapamil in antihypertensive therapy. J Cardiovasc Pharmacol 4:S350-S357

Google Scholar 

Carlsen RC, Larson DB, Walsh DA (1985) A fast-twitch oxidative glycolytic muscle with a robust inward calcium current. Can J Physiol Pharmacol 63:958–965

PubMed  CAS  Google Scholar 

Duncombe WG (1964) The colorimetric micro-determination of non-esterified fatty acids in plasma. Clin Chim Acta 9:122–125

Article  PubMed  CAS  Google Scholar 

Franciosa JA, Willen M (1984) Nitrendipine effects on exercise and hemodynamics in hypertension. Clin Pharmacol Ther 35:241

Google Scholar 

Gordon N, Russel H, Rensburg J van, Kowalski D, Celliers C, Cilliers D, Mijburgh D (1985) Effects of beta1-selective adrenoceptor blockade and calcium antagonism on exercise intensity prescription. Med Sci Sports Exerc 17:284

Google Scholar 

Halperin AK, Gross KM, Rogers JF, Cubeddu LX (1984) Verapamil and propranolol in essential hypertension. Clin Pharmacol Ther 36:750–758

Article  PubMed  CAS  Google Scholar 

Herwaarden CLA van, Binkhorst RA, Fennis JFM, Laar A van't (1979) Effects of propranolol and metoprolol on hemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients. Br Heart J 41:99–105

PubMed  Google Scholar 

Juhlin-Dannfelt A (1983) Beta-adrenoceptor blockade and exercise: Effects on endurance and physical training. Acta Med Scand [Suppl. 672]:49–54

Google Scholar 

Katz AM, Hager WD, Messineo FC, Pappano AJ (1985) Cellular actions and pharmacology of the calcium channel blocking drugs. Amer J Med 79 [Suppl. 4A]:2–10

Article  CAS  Google Scholar 

Kindermann W, Schmitt WM, Biro G, Schnabel A (1981) Metabolismus und hormonelles Verhalten bei Körperarbeit unter akuter Beta1-Sympathikolyse. Z Kardiol 70:406–412

PubMed  CAS  Google Scholar 

Kindermann W, Schmitt W, Stengele E (1985) Einflu\ von Calcium-Antagonisten auf die körperliche LeistungsfÄhigkeit und den Metabolismus. Dtsch Med Wochenschr 110:1657–1661

Article  PubMed  CAS  Google Scholar 

Leonetti G, Cuspidi C, Sampieri L, Terzoli L, Zanchetti A (1982) Comparison of cardiovascular, renal and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects. J Cardiovasc Pharmacol 4 [Suppl 3]:S319-S324

PubMed  Google Scholar 

Lundborg P, Astroem H, Bengtsson C, Fellenius E, Schenk H von, Svensson L, Smith U (1981) Effects of beta-adrenoceptor blockade on exercise performance and metabolism. Clin Sci 61:299–305

PubMed  CAS  Google Scholar 

Lund-Johansen P (1983) Central hemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol, pindolol and bunitrolol. Eur Heart J 4 [Suppl. D]:1–12

PubMed  Google Scholar 

Lund-Johansen P (1984) Hemodynamic effects of verapamil in essential hypertension at rest and during exercise. Acta Med Scand [Suppl. 681]:109–115

Google Scholar 

MacFarlane BJ, Hughson RL, Green HJ, Walters DJ, Ranney DA (1983) Effects of oral propranolol and exercise protocol on indices of aerobic function in normal man. Can J Physiol Pharmacol 61:1010–1016

PubMed  CAS  Google Scholar 

Mooy J, Schols M, Baak M van, Hooff M van, Muijtjens A, Rahn KH (1985) Pharmacokinetics of verapamil in patients with renal failure. Eur J Clin Pharmacol 28:405–410

Article  PubMed  CAS  Google Scholar 

Mooy J, Böhm R, Petri H, Kemenade J van, Baak M van, Rahn KH (1986) Exercise tolerance in hypertensive patients during treatment with verapamil and propranolol. Naun Schmied Arch Pharmacol 332 [Suppl. 2]:R98

Google Scholar 

Murphy MB, Dollery A, eds (1983) Calcium antagonists in the treatment of hypertension. Hypertension 5 [Suppl.]:66–112

Neugebauer G (1978) Comparative cardiovascular actions of verapamil and its major metabolites in the anesthetized dog. Cardiovasc Res 12:247–254

PubMed  CAS  Google Scholar 

Opie LH (1984) Calcium antagonists. Mechanisms, therapeutic indications, and reservations: a review. Quart J Med New Series LIII 209:1–16

Google Scholar 

Schütz E, Ha HR, Bühler FR, Follath F (1982) Serum concentration and antihypertensive effect of slow-release verapamil. J Cardiovasc Pharmacol 4:S346-S349

PubMed  Google Scholar 

Stein DT, Lowenthal DT, Porter S, Falkner B, Bravo EL, Mare TW (1984) Effects of nifedipine and verapamil on isometric and dynamic exercise in normal subjects. Am J Cardiol 54:386–389

Article  PubMed  CAS  Google Scholar 

Yamaguchi T, Obayashi K, Mandel WJ (1978) Electrophysiological effects of verapamil. Cardiovasc Res 12:597–608

Article  PubMed  CAS  Google Scholar 

Zerbe GO (1979) Randomization analysis of randomized block design extended to growth and response curves. Community Stat Theor Method A8:191–205

Google Scholar